UCB
ucb.com Direct investor
UCB is a global biopharmaceutical company focused on neurological and autoimmune conditions. It also operates UCB Ventures, which invests in companies and technologies that could transform the lives of people with severe diseases.
UCB is a corporate venture arm headquartered in Brussels, Belgium, founded in 1928. It invests directly in companies.
“UCB Ventures invests in pioneering companies and technologies that have the potential to transform the lives of people living with severe diseases.”
— UCB, own website
- Layer
- Direct investor
- Stage
- Unknown
- Founded
- 1928
Team, as UCB publishes it
- Jean-Christophe Tellier Chief Executive Officer & Chairman of the Executive Committee
- Emmanuel Caeymaex Executive Vice President Patient Evidence
- Sandrine Dufour Executive Vice President Chief Financial Officer
- Fiona du Monceau Executive Vice President Chief Commercial Officer
- Jean-Luc Fleurial Executive Vice President & Chief Human Resources Officer
- Alistair Henry Executive Vice President Chief Scientific Officer
- Jacques Marbehant Executive Vice President Patient Supply
- Denelle Waynick Johnson Executive Vice-President & General Counsel
Names and roles exactly as listed on ucb.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 1 co-investors found.
- Savola Group 1 shared company: readspeaker.com
Where this comes from
Every fact above was read from a page UCB publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.ucb.com/name, is_investor, layer, type, thesis_quote, thesis_quote_page, description, status
- https://www.ucb.com/about-ucbhq_country, hq_city, founded
- https://www.ucb.com/about-ucb/managementpeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 6746 · added 2026-09-03 · link last verified 2026-09-06 · confidence medium
Similar investors
- Lab BoxCorporate venture · Seed – Growth · Brussels, Belgium
- FinindusCorporate venture · Seed – Growth · Belgium
- NinepointfiveCorporate venture · Seed – Series B · Antwerp, Belgium
- KBC Focus FundCorporate venture · Seed – Growth · Belgium
- Accenture VenturesCorporate venture · United States
- Ad4VenturesCorporate venture · Seed – Growth · Cologno Monzese, Italy